BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1429075)

  • 1. Starting therapy for an HIV-infected patient.
    Blais FX
    J Am Osteopath Assoc; 1992 Sep; 92(9):1153-4. PubMed ID: 1429075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing a patient with progressive HIV disease.
    Blais FX
    J Am Osteopath Assoc; 1992 Oct; 92(10):1267-8. PubMed ID: 1459873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple guidelines for HIV testing in the physician's practice.
    Calabrese LH; Condoluci D
    J Am Osteopath Assoc; 1992 Apr; 92(4):499-500. PubMed ID: 1601692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Workup of a patient with newly diagnosed HIV infection.
    Condoluci DV
    J Am Osteopath Assoc; 1992 Aug; 92(8):1039-40. PubMed ID: 1429063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to recognize patients at risk or infected with HIV.
    Blais FX
    J Am Osteopath Assoc; 1992 Feb; 92(2):234-5. PubMed ID: 1544828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special considerations for HIV infection in women.
    Tranen BT
    J Am Osteopath Assoc; 1992 Nov; 92(11):1437-8. PubMed ID: 1289314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counseling the patient with newly diagnosed HIV infection.
    Tranen BT
    J Am Osteopath Assoc; 1992 Jun; 92(6):785-6. PubMed ID: 1612944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real risks of HIV transmission to physicians and their staffs. American Osteopathic Association Task Force on AIDS.
    Calabrese L
    J Am Osteopath Assoc; 1992 Jan; 92(1):109-11. PubMed ID: 1559852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The family physician's contribution to the care of patients in the final stages of HIV infection.
    Calabrese LH
    J Am Osteopath Assoc; 1992 Dec; 92(12):1523-4. PubMed ID: 1483882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helping patients to reduce their risk of acquiring sexually transmitted disease.
    Braun JF
    J Am Osteopath Assoc; 1992 May; 92(5):646-7. PubMed ID: 1601700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspectives on antiretroviral therapy.
    Fletcher CV
    Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Didanosine (DDI) alone is now considered the first-line therapy for symptomatic children infected with the human immunodeficiency virus (HIV).
    J Am Osteopath Assoc; 1996 Jun; 96(6):339. PubMed ID: 8690619
    [No Abstract]   [Full Text] [Related]  

  • 13. Continued zidovudine or didanosine for human immunodeficiency virus infection.
    Behrman RE; Kammerman LA; Feigal DW
    N Engl J Med; 1992 Nov; 327(22):1598-9. PubMed ID: 1435893
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center.
    Pediatr Infect Dis J; 1993 Jun; 12(6):513-22. PubMed ID: 8393969
    [No Abstract]   [Full Text] [Related]  

  • 15. Using convergent combination therapy, researchers stopped the human immunodeficiency virus (HIV) from reproducing in test tubes.
    J Am Osteopath Assoc; 1993 Apr; 93(4):431. PubMed ID: 8478218
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.
    Raboud JM; Montaner JS; Rae S; Kahn J; Hammer SM; Katzenstein DA; Pavia A; Dolin R; Hughes MD; Cross A; Beltangady M; Gatell J; Dunkle L; Smaldone L
    Antivir Ther; 1997 Dec; 2(4):237-47. PubMed ID: 11327443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.
    Bozzette SA; Kanouse DE; Duan N; Berry S; Richman DD
    Antivir Ther; 1996 Jan; 1(1):21-32. PubMed ID: 11322256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E
    Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
    Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
    Khajotia RR; Feigley CE; Lee E; Gu J
    AIDS; 1998 Jan; 12(2):222-4. PubMed ID: 9468376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.